Back
Citius Pharmaceuticals Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
46
CTXR
Citius Pharmaceuticals
Last Price:
0.33
Seasonality Move:
21.66%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing selling pressure, which indicates risk of future bearish movement.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.39 | Sell |
| 20-day SMA: | 0.38 | Buy |
| 50-day SMA: | 0.44 | Sell |
| 200-day SMA: | 0.65 | Sell |
| 8-day EMA: | 0.41 | Sell |
| 20-day EMA: | 0.4 | Sell |
| 50-day EMA: | 0.45 | Sell |
| 200-day EMA: | 0.63 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.64 | Sell |
| Chaikin Money Flow: | -1938218 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.35 - 0.41) | Buy |
| Bollinger Bands (100): | (0.4 - 0.76) | Sell |
Citius Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.39 while CTXR 8-day simple moving average is 0.39, which is a Sell signal.
- The stock price of CTXR is 0.39 while Citius Pharmaceuticals 20-day SMA is 0.38, which makes it a Buy.
- Citius Pharmaceuticals 50-day simple moving average is 0.44 while CTXR share price is 0.39, making it a Sell technically.
- CTXR stock price is 0.39 and Citius Pharmaceuticals 200-day simple moving average is 0.65, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
46
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.39. The Score for CTXR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
69.71M
Price in USD:
0.39
Share Volume:
2.38M
Citius Pharmaceuticals 52-Week Range
52-Week High:
1.07
52-Week Low:
0.31
Sell
46
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?
The Citius Pharmaceuticals stock price is 0.39 USD today. -
Will CTXR stock go up or go down?
Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.39 while CTXR 8-day exponential moving average is 0.41, which is a Sell signal.
- The stock price of CTXR is 0.39 while Citius Pharmaceuticals 20-day EMA is 0.40, which makes it a Sell.
- Citius Pharmaceuticals 50-day exponential moving average is 0.45 while CTXR share price is 0.39, making it a Sell technically.
- CTXR stock price is 0.39 and Citius Pharmaceuticals 200-day simple moving average is 0.63, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
- CTXR Moving Average Covergence Divergence (MACD) indicator is -0.01, suggesting Citius Pharmaceuticals is a Sell
- Citius Pharmaceuticals Relative Strength Index (RSI) is 46.64, which suggest Citius Pharmaceuticals is oversold
- The Bollinger Bands (25) for Citius Pharmaceuticals is (0.35 - 0.41), which suggest Citius Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Citius Pharmaceuticals is (0.4 - 0.76), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.